Potential application of nano-hydroxyapatite in treatment of osteoporotic bone healing - a preliminary study
Yang Xiao,Xie Pengfei,Chen Xuening,Zhu Xiangdong,Fan Yujiang,Zhang Xingdong
DOI: https://doi.org/10.3389/conf.FBIOE.2016.01.01228
IF: 5.7
2016-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Event Abstract Back to Event Potential application of nano-hydroxyapatite in treatment of osteoporotic bone healing - a preliminary study Xiao Yang1, Pengfei Xie1, Xuening Chen1, Xiangdong Zhu1, Yujiang Fan1 and Xingdong Zhang1 1 Sichuan University, National Engineering Research Center for Biomaterials, China Osteoporotic fracture is a significant cause of morbidity and mortality in elderly population. Delayed bone union or nonunion often occurred in clinical osteoporotic fracture. Natural osteoporotic bone hydroxyapatite crystal is within nano-dimension[1]. Thus, we hypothesized that material which contains hydroxyapatite nano particles (HANP) would have good biocompatibility with osteoporotic bone derived osteoblast (bone forming cell). HANP is made by traditional two-step synthesis method and later confirmed by TEM and XRD. Primary osteoblast culture is isolated from osteoporotic and healthy rat long bones. The osteoblasts are treated with different concentration of HANP, ranging from 0 to 500 ug/ml. MTT, confocal imaging, ELISA and RT-PCR were done to characterize cellular response to HANP. We found that 100 ug/ml HANP treated osteoporotic osteoblast had larger cell spread area (+48%, p=0.034) and higher bone related protein secretion (alkaline phosphatase and osteocalcin etc.). At this concentration of HANP, bone forming marker genes: bsp, ocn, alp and osx mRNA expression is significantly increased (p<0.05 vs. 0 ug/ml). These positive alterations may attribute to a higher cellular calcium ion concentration, measured by flow cytometry. Significant increase in cellular sodium-potassium ATPase level with exposure to 100 ug/ml HANP played an important role in cellular calcium intake. Animal bone defect model showed that with 100 ug/ml injection of HANP, ovariectomized rat had faster bone healing rate as compare with non-treated control. We conclude that below 500 ug/ml, HANP is non-toxic and could effectively promote osteoporotic osteoblast differentiation, as well as bone integration process. Materials delivering HANP would be a promising solution for osteoporotic bone nonunion. National Science and Technology Supporting Project, Grant No. 2012BAI17B01References:[1] Nanohydroxyapatite application to osteoporosis management. 2013. Journal of Osteoporosis. Keywords: nanoparticle, Biocompatibility, Cell response, Bone repair Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: Poster Topic: Biomaterials in musculoskeletal orthopeadics and tissues Citation: Yang X, Xie P, Chen X, Zhu X, Fan Y and Zhang X (2016). Potential application of nano-hydroxyapatite in treatment of osteoporotic bone healing - a preliminary study. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01228 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Xiao Yang Pengfei Xie Xuening Chen Xiangdong Zhu Yujiang Fan Xingdong Zhang Google Xiao Yang Pengfei Xie Xuening Chen Xiangdong Zhu Yujiang Fan Xingdong Zhang Google Scholar Xiao Yang Pengfei Xie Xuening Chen Xiangdong Zhu Yujiang Fan Xingdong Zhang PubMed Xiao Yang Pengfei Xie Xuening Chen Xiangdong Zhu Yujiang Fan Xingdong Zhang Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.